Legato Capital Management LLC Harmony Biosciences Holdings, Inc. Transaction History
Legato Capital Management LLC
- $718 Million
- Q4 2024
A detailed history of Legato Capital Management LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 26,720 shares of HRMY stock, worth $1.03 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
26,720
Previous 21,214
25.95%
Holding current value
$1.03 Million
Previous $847,000
8.5%
% of portfolio
0.13%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
246Shares Held
45.6MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$434 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$226 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$134 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$101 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.2 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.29B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...